23 Sep Sano Genetics
Ben Jackson, Vice President of Commercial
Oct. 5 | 9:00am | FLW Ballroom G
Cambridge, UK
(Private)
Today, sponsors invest significant resources finding and characterizing patient cohorts — running campaigns, commissioning studies, building from scratch. Yet in many cases, that data already exists: in prior studies, registries, health records, and consented genetic databases. The challenge is accessing it, recontacting patients and caregivers, and making it actionable.
Sano Genetics solves this. For cell and gene therapy developers who rely on precise, genotype-driven patient identification, Sano is the precision patient platform that unifies recruitment, eligibility screening, at-home genetic testing, and long-term engagement in one compliant, modular infrastructure. Unlike CROs or point solutions, Sano enables access to existing patient pools through structured recontact — accelerating enrollment, compiling existing biomarker data, and supporting bespoke data collection at a commercial model that reduces upfront investment.
Sano’s 360° platform reduces screen failures, builds reusable genotype-tagged cohorts for clinical development and post-approval evidence, and ensures data and patient relationships carry forward across programs.